Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study
PaperCitations, authors & open-access status
Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 295 citations, 2010 year and closed oa status.
295
Citations
2010
Year
closed
OA Status